[Changes in the enzyme activity in the brain structures of August rats under the influence of the delta sleep-inducing peptide against a background of prolonged L-dihydroxyphenylalanine administration].
Sergutina. A V AV; Rakhmanova. V I VI
Key Findings
- DSIP reduced monoamine oxidase (MAO) activity using tryptamine as a substrate in the hippocampus.
- DSIP lowered aminopeptidase and glutamate dehydrogenase activities in the nucleus accumbens.
- DSIP did not alter acetylcholinesterase or MAO activity when serotonin was the substrate in any brain region studied.
Practical Outcomes
- The data hint that DSIP can modulate certain brain enzymes involved in stress and neurotransmitter metabolism, but the evidence is limited to a specific animal model and does not provide dosing or clear health benefits for humans. Biohackers should treat this as mechanistic insight rather than a basis for new DSIP protocols.
Summary
In a rat study, the sleep‑inducing peptide DSIP changed the activity of a few brain enzymes linked to stress and neurotransmitter breakdown, but it didn’t affect other key enzymes. The work was done in a specific strain of stressed rats given L‑DOPA, so it’s unclear how the findings translate to people.
Abstract
Quantitative cytochemical methods revealed the decrease of MAO activity (substrate--tryptamine) in the hippocampus of L-dioxytryptamine treated August rats genetically predisposed to emotional stress under the effect of delta sleep inducing peptide (DSIP). Activities of aminopeptidase and glutamate dehydrogenase were decreased in n.accumbens while changes of the activities of these enzymes were not significant in the layers III and V of sensomotor cortex and n.caudatus. In all brain structures Ache and MAO (substrate 5-hydroxytryptamine) activities were not influenced by DSIP.
Study Information
pubmed
1999